ATOM Consortium Webinar Series Presents: An Alternative Approach and Business Model to Accelerate Drug Discovery
Cancer researchers and professionals involved in drug discovery are invited to join the Accelerating Therapeutics for Opportunities in Medicine (ATOM) Consortium’s first webinar in a new series of webinars. ATOM integrates high performance computing, diverse biological data, and emerging biotechnologies to create a platform to reduce the drug discovery timeline. Dr. John Baldoni, CEO of ATOM Research Alliance, will talk about the ATOM Modeling Pipeline (AMPL), an open-source data-driven modeling pipeline that supports machine learning and molecular featurization tools. Key takeaways:
|
In Dr. John Baldoni’s 41 years in the pharmaceutical industry, he has led organizations spanning drug discovery, preclinical development, manufacturing, and technology development. He is a proponent of seeking, integrating, and implementing innovative approaches to drug discovery and development. John worked with public sector and government partners to form the ATOM Consortium and to create the non-profit ARA. In addition to his work with ARA, he works with cutting edge technology companies to translate innovation to value.
Upcoming Events
- Social Determinants of Health with Large/Moderate Language Models on EHR Data: AI in Immuno-oncologyJuly 30, 2024CCDI Federated Data: Enhancing Data DiscoverabilityAugust 13, 2024Leveraging High-Performance Computing Resources and Using QIIME 2 to Advance Your Microbiome ProjectsAugust 27, 2024 - August 29, 2024NCI Office of Data Sharing’s Annual Data Sharing Symposium: Driving Cancer Advances Through Impactful ResearchOctober 16, 2024The Cancer Research Data Commons 2024 Fall Symposium: Ten Years of Empowering Cancer ResearchersOctober 16, 2024 - October 17, 2024